Troponin identifies highest-risk angina patients
This article was originally published in Clinica
Executive Summary
Screening blood for elevated troponin I levels could help identify whether unstable angina sufferers, who are in a critical phase of coronary heart disease, are at higher risk of death or heart attack, according to a 2,240-patient German study. The researchers presented their findings at the European Society of Cardiology (ESC) meeting in Barcelona last week.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.